{"id":"NCT00381485","sponsor":"Organon and Co","briefTitle":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)","officialTitle":"A 12-Week Efficacy and Safety Study of Two Doses of Mometasone Furoate/Formoterol Combination Formulation Compared With Mometasone Furoate Monotherapy, in Persistent Asthmatics Previously Treated With High-Dose Inhaled Glucocorticosteroids","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07-01","primaryCompletion":"2008-01-01","completion":"2008-01-01","firstPosted":"2006-09-27","resultsPosted":"2011-03-07","lastUpdate":"2024-05-20"},"enrollment":834,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Mometasone furoate/formoterol (MF/F) combination","otherNames":["SCH 418131"]},{"type":"DRUG","name":"Mometasone furoate/formoterol (MF/F) combination","otherNames":["SCH 418131"]},{"type":"DRUG","name":"Mometasone furoate MDI (MF MDI)","otherNames":["SCH 32088"]}],"arms":[{"label":"MF/F MDI 400/10 mcg BID","type":"EXPERIMENTAL"},{"label":"MF/F MDI 200/10 mcg BID","type":"EXPERIMENTAL"},{"label":"MF MDI 400 mcg BID","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, multicenter, double blind, parallel-group study evaluating the efficacy of mometasone furoate/formoterol fumarate (MF/F) metered dose inhaler (MDI) 400/10 mcg twice daily (BID) compared with MF MDI 400 mcg BID for 12 weeks. Prior to the 12-week double-blind treatment period, subjects will receive open-label MF MDI 400 mcg BID for 2 to 3 weeks during the run-in period. Efficacy will be measured by the area under the curve from 0 to 12 hours \\[AUC\\](0-12 hr) of the change from Baseline to the Week 12 Endpoint in forced expiratory volume in one second (FEV1).","primaryOutcome":{"measure":"Mean Area Under the Time Curve From 0 to 12 Hours (AUC(0-12 Hours)) of Change From Baseline to Week 12 in Forced Expiratory Volume (Liters) in 1 Second (FEV1)","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"MF/F MDI 400/10 mcg BID","deltaMin":4.19,"sd":3.63},{"arm":"MF/F MDI 200/10 mcg BID","deltaMin":3.59,"sd":3.63},{"arm":"MF MDI 400 mcg BID","deltaMin":2.04,"sd":3.63}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":23},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["36472162","20687982"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":255},"commonTop":["Nasopharyngitis"]}}